SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-034290
Filing Date
2021-10-12
Accepted
2021-10-12 08:00:31
Documents
8
Period of Report
2021-12-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20000819x1_def14a.htm DEF 14A 951313
2 logo_galectinx1.jpg GRAPHIC 26119
3 ny20000819x1_apa01.jpg GRAPHIC 31153
4 ny20000819x1_apa02.jpg GRAPHIC 16775
5 ny20000819x1_pc01.jpg GRAPHIC 752413
6 ny20000819x1_pc02.jpg GRAPHIC 528733
7 sig_jlewis.jpg GRAPHIC 12813
8 sig_jwcallicutt.jpg GRAPHIC 17818
  Complete submission text file 0001140361-21-034290.txt   2859716
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31791 | Film No.: 211316939
SIC: 2834 Pharmaceutical Preparations